Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025

Treatment of focal segmental glomerular sclerosis (FSGS) using therapeutically effective oral doses of 10-nitro-9(E)-octadec-9-enoic acid

US Patent 10537541 · Granted Jan 21, 2020

Assignee

Inventors

View full patent text on Google Patents →